Prevalen of Ceceliac Disease in Patients of Hospital UNIVALLE 2016- 2017
DOI:
https://doi.org/10.52428/20756208.v13i34.488Keywords:
Celiac disease, Autoinmunity, Serological tests, Enteropathy, GlutenAbstract
Celiac disease is a chronic enteropathy of the small intestinal mucosa caused by gluten intolerance, which results in villous atrophy, malabsorption and clinical symptoms that manifest in childhood or adulthood. The pathogenesis consists in the interaction of the proteins present in wheat, barley, oats and rye between genetic, immunological and environmental factors, which interact with the molecules of human leukocyte antigens to activate an immunological response in the mucosa of the small intestine, producing tissue damage. Serological tests and duodenal biopsy (the gold standard) are important for diagnosis. A retro-spective cross-sectional study was carried out on 23 patients who attended the specialty of gastroenterology at Hospital UNIVALLE Cochabamba between 2016 -2017, the tests EMA, tTGA and antigliadin and upper endoscopy were determined, observing greater positivity in the female sex than in the male. Studies conducted in Europe, the United States and Latin America have found frequencies of this disease between 1/100 - 1/300 and the diagnosis depends on the degree of clinical suspicion. The prevalence data found confirm that celiac disease constitutes a public health problem in our country, which could justify the establishment of a study program. The regions with the highest prevalence (1 %) are Europe and the USA, where traditional food is based on foods with gluten. 10801 patients were attended during the 2016 and 2017 procedures, with a prevalence of 0,21 %, with a low prevalence in our country, due to the lack of studies and the clinic.
Downloads
References
1. FASANO A, BERTI 1, GERARDUZZI T, NOT T, COLLETTI R, DRAGOS, et al. Prevalence of Celiac Disease in At-Risk and Not- At-Risk Groups in the United States. EE.UU.: Arch lntern Med 2003. pg. 286-292. https://doi.org/10.1001/archinte.163.3.286
2. HORWITZ A, SKAABYT, KARHUS LL, SCHWARZ P, JORGENSEN T, RUMESSEN JJ, et al. Screening far celiac disease in Danish adults. Chile: Scand J Gastroenterol 2015. https://doi.org/10.3109/00365521.2015.1010571
3. BURGER JP, ROOVERS EA, DRENTH JP, MEIJER JW yWAHAB PJ. Rising inci-dence of celiac disease in the Netherlands: an analysis of temporal trends from 1995 to 2010. EE.UU.: Scand J Gastroenterol 2014; 49 (8): 933-941. https://doi.org/10.3109/00365521.2014.915054
4. MINISTERIO DE SALUD DE CHILE. Encuesta Nacional de Salud 2009-2010. Tomo l. [Internet] 2016 [Consultado en noviembre de 2017] Disponible en: www.minsal.cl/portal/url/item/bcb03d7bc28b64dfe0400101650l2d23.pdf
5. PETERS U, ASKLING J, GRIDLEY G, EKBOM A y LINET M. Causes of death in patients with celiac disease in a population-based Swedish Cohort. EE.UU.: Arch lntern Med 2003; 163:1566-1572. https://doi.org/10.1001/archinte.163.13.1566
6. CORRAO G, CORAZZA GR, BAGNARDI V, BRUSCO G, CIACCI C, COTTONE M, et al. Mortality in pa-tients with coeliac disease and their relatives: a cohort study. EE.UU.: Lancet 2001; 358: 356-361. https://doi.org/10.1016/S0140-6736(01)05554-4
7. KAGNOFF, M. Overview and Pathogenesis of Celiac Disease. California, EE.UU.: Gastroenterology 2005; 128:10-18. https://doi.org/10.1053/j.gastro.2005.02.008
8. KILMARTIN C, LYNCH S, ABUZAKOUK M, WIESER H y FEIGHERY C. Avenin fails to induce a Thl response in coeliac tissue following in vitro culture. Sevilla, España: Gut 2003; 52:47-52. https://doi.org/10.1136/gut.52.1.47
9. SHAN L, MOLBERG 0, PARROT 1, HAUSCH F, FILIZ F, GRAY G, et al. Structural basis far gluten intolerance in celiac sprue. Zurich, Suiza: Science 2002; 297:2275-2279. https://doi.org/10.1126/science.1074129
10. DI SABATINO A y CORAZZA G. Coeliac disease. EE.UU.: Lancet 2009; 373:1480-1494. https://doi.org/10.1016/S0140-6736(09)60254-3
11. GREEN P y CELLIER C. Celiac disease. EE.UU.: N Engl J Med V. 2007; 357:1731-1743. https://doi.org/10.1056/NEJMra071600
12. MOHAMED B, FEIGHERY C, KELLY J, COATES C, O'SHEA U, BARNES L, et al. lncreased Protein Expression of Matrix Metalloproteinases -1, -3, and -9 and TIMP-1 in Patients with Gluten-Sensitive Enteropathy. EE.UU.: Dig Dis Sci. 2006; 51:1862-1868. https://doi.org/10.1007/s10620-005-9038-4
13. SOLLID LM y LIE BA. Celiac di sea se genetics: curren! concepts and practica! applications. EE.UU.: Clin Gastroenterol Hepatol 2005; 3: pg. 843-851. Oslo, Norway. https://doi.org/10.1016/S1542-3565(05)00532-X
14. ARAYA M, OYARZÚN A, LUCERO Y, ESPINOSA N y PÉREZ-BRAVO F. DQ2, DQ7 and DQ8 Distribution and Clinical Manifestations in Celiac Cases and Their First-Degree Relatives. Chile: Nutrients 2015; 7:4955-4965. https://doi.org/10.3390/nu7064955
15. IVARSSON A, HERNELL O, STENLUND H y PERSSON LA. Breast-feeding protects against celiac disease. EE.UU.: Am J Clin Nutr 2002; 75:914-921. https://doi.org/10.1093/ajcn/75.5.914
16. LEBWOHL B, BLASER MJ, LUDVIQSSON JF, GREEN PH, RUNDLE A, SONNEN-BERG A, et al. Decreased risk of celiac disese in patients with Helicobacter pylori colonization. EE.UU.: Am J Epidemiol 2013; 178:1721-1730. https://doi.org/10.1093/aje/kwt234
17. O'LEARY C, WIENEKE P, BUCKLEY S, O'REGAN P, CRONIN ce, QUIGLEY E, et al. Celiac disease and irritable bowel-type symptoms. Reino Unido: Am J Gastroenterol 2002; 97:1463-1467. https://doi.org/10.1111/j.1572-0241.2002.05690.x
18. TRONCONE R, GRECO L, MAYER M, PAPARO F, CAPUTO N, MICILLO M, et al. Latent and potential coeliac disease. Sao Paulo, Brazil: Acta Paediatr 1996; 412:10-14. https://doi.org/10.1111/j.1651-2227.1996.tb14240.x
19. LUDVIGSSON J, LEFFLER D, BAI C, BIAGI F, FASANO A, GREEN P, et al. The Oslo definitions for coeliac disease and related terms. EE.UU.: Gut 2013; 62:43-52. https://doi.org/10.1136/gutjnl-2011-301346
20. VOLTA U, CAIO G, STANGHELLINI V y DE GIORGIO R. The changing clinical profile of celiac disease: a 15-year experience (1998-2012) in an ltalian referral center. Italia: BMC Gastroenterol 2014; 14:194-202. https://doi.org/10.1186/s12876-014-0194-x
21. BRAR P, KWON GY, EGBUNA 11, HOLLERAN S, RAMAKRISHNAN R, BHAGAT G, et al. Lack of correlation of degree of villous atrophy with severity of clinical presentation of coeliac disease. Netherlands: Dig Liver Dis 2007; 39:26-29. https://doi.org/10.1016/j.dld.2006.07.014
22. MURRAY JA, RUBIO-TAPIA A, VAN DYKE CT, BROGAN DL, KNIPSCHIELD MA, LAHR B, et al. Mu casal atrophy in celiac disease: extent of involvement, correlation with clinical presentation, and response to treatment. Serbia: Clin Gastroenterol Hepatol 2008; 6:186-193. https://doi.org/10.1016/j.cgh.2007.10.012
23. MATYSIAK-BUDNIK T, MALAMUT G, DE SERRE N, GROSDIDIER E, SEGUIER S, BROUSSE N, et al. Longterm follow-up of 61 coeliac patients diagnosed in childhood: evolution toward latency is possible on a normal diet. EE.UU.: Gut 2007; 56:1379-1386. https://doi.org/10.1136/gut.2006.100511
24. CZAJA-BULSA G. Non coeliac gluten sensitivity. EE.UU.: Clin Nutr 2015; 34 (2):189-194. https://doi.org/10.1016/j.clnu.2014.08.012
25. NAVARRO E y ARAYA M. Sensibilidad no celíaca al gluten. Una patología más que responde al gluten. Santiago de Chile, Chile Rev Med Chile 2015; 143:619-626. https://doi.org/10.4067/S0034-98872015000500010
26. LEFFLER DA y SCHUPPAN D. Update on serologic testing in celiac disease. EE.UU.: Am J Gastroenterol 2010; 105:2520-2524. https://doi.org/10.1038/ajg.2010.276
27. RUBIO-TAPIA A, HILL 1, KELLY C, CALDERWOOD A y MURRAY J. ACG Clinical Guidelines: Diagnosis and Management of Celiac Disease. EE.UU.: Am J Gastroenterol 2013; 108:656-676. https://doi.org/10.1038/ajg.2013.79
28. ROSTOM A, DUBÉ C, CRANNEY A, SALOOJEE N, SY R, GARRITTY C, et al. The Diagnostic Accuracy of Serologic Tests for Celiac Disease: A Systematic Review. EE.UU.: Gastroenterology 2005; 128:38-46. https://doi.org/10.1053/j.gastro.2005.02.028
Downloads
Published
Issue
Section
License
Copyright (c) 2018 Jacqueline Borda Zambrana , Edson Flores , Sarah Vasquez y Yhassyre Abularach
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License 4.0 that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
How to Cite
